ABN AMRO
17.4.2026 08:00:00 CEST | Globenewswire | Press release
Progress on ABN AMRO share buyback programme 10 April – 16 April 2026
Progress on ABN AMRO share buyback programme 10 April – 16 April 2026
Progress on ABN AMRO share buyback programme 10 April – 16 April 2026
17 April 2026
ABN AMRO reports the transaction details related to the start of the €250 million share buyback programme announced on 27 March 2026.
During the week of 10 April 2026 up to and including 16 April 2026 a total of 1,000,000 shares and depositary receipts were repurchased at an average price of € 29.66 for a total amount of € 29,659,420.
For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme
To date the total consideration for shares and depositary receipts repurchased amounts to € 74,063,440 representing 29.63% of the overall share buyback programme.
This press release is published by ABN AMRO Bank N.V. and contains inside information within the meaning of article 7 (1) to (4) of Regulation (EU) No 596/2014 (Market Abuse Regulation).
Note for the editor, not for publication:
ABN AMRO Press Office: Jarco de Swart, E-mail: pressrelations@nl.abnamro.com, phone number: +31 (0)20 6288900.
ABN AMRO Investor Relations: John Heijning, E-mail: investorrelations@nl.abnamro.com, phone number +31 (0)20 6282282.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Royal UNIBREW A/S10.8.2026 13:35:04 CEST | Press release
Share buy-back program
Orion Oyj10.8.2026 13:05:00 CEST | Press release
Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint
Netcompany Group A/S10.8.2026 13:01:50 CEST | Press release
Transactions in connection with share buyback programme
Curium10.8.2026 13:00:00 CEST | Press release
Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology
Tilray Brands, Inc.10.8.2026 13:00:00 CEST | Press release
BrewDog Claims London's Summer Park Season with ‘Park IPA’
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom